Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood

• Julie Rytlewski ,

  Contributed equally to this work with: Julie Rytlewski, Shibing Deng

  Roles Data curation, Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing

  Affiliation Adaptive Biotechnologies, Seattle, Washington, United States of America

  http://orcid.org/0000-0001-5244-6790

  ⨯
• Shibing Deng ,

  Contributed equally to this work with: Julie Rytlewski, Shibing Deng

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Pfizer Incorporated, La Jolla, California, United States of America

  http://orcid.org/0000-0002-2867-263X

  ⨯
• Tao Xie,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Pfizer Incorporated, La Jolla, California, United States of America

  ⨯
• Craig Davis,

  Roles Project administration, Resources, Writing – review & editing

  Affiliation Pfizer Incorporated, La Jolla, California, United States of America

  http://orcid.org/0000-0002-1703-451X

  ⨯
• Harlan Robins,

  Roles Conceptualization, Project administration

  Affiliations Adaptive Biotechnologies, Seattle, Washington, United States of America, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Erik Yusko ,

  Roles Conceptualization, Formal analysis, Methodology, Software, Writing – original draft

  * E-mail: eyusko@adaptivebiotech.com (EY); jadwiga.r.bienkowska@pfizer.com (JB)

  Affiliation Adaptive Biotechnologies, Seattle, Washington, United States of America

  ⨯
• Jadwiga Bienkowska

  Roles Investigation, Methodology, Resources, Writing – original draft

  * E-mail: eyusko@adaptivebiotech.com (EY); jadwiga.r.bienkowska@pfizer.com (JB)

  Affiliation Pfizer Incorporated, La Jolla, California, United States of America

  ⨯